Dagrafors Duo

Dagrafors Duo combines sitagliptin and dapagliflozin for oral use, offering a dual-action approach to managing blood sugar levels. This medication is designed to support individuals with type 2 diabetes in their treatment regimen.

Dagrafors Duo is primarily used to help manage type 2 diabetes by improving blood sugar control. The combination of sitagliptin and dapagliflozin works to enhance the body's natural processes that regulate glucose levels. This medication is often prescribed as part of a broader treatment plan that includes diet and exercise.

Common effects of Dagrafors Duo may include improved blood sugar control, which can help reduce symptoms associated with high blood sugar levels. Some individuals may experience side effects such as urinary tract infections or gastrointestinal discomfort, although these vary from person to person.

It is important to use Dagrafors Duo as directed by a healthcare professional. Individuals with certain medical conditions, such as kidney problems, should discuss their health status with a doctor before starting this medication. Always follow the prescribed dosage and monitor blood sugar levels regularly.

Dagrafors Duo may interact with other medications, including certain antibiotics, diuretics, and other diabetes treatments. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.